Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-04-06Clinical Trial Update: Clinical Utility Study of a Low-Cost Hand-Held Breast Scanner [NA]
Clinical utility study of a low-cost hand-held breast scanner completed; results posted in 2020. No specific regulatory outcome reported.
-
CLINICAL_TRIALS research · 2020-04-06Clinical Trial Update: IMAging With Opto-acoustics to downgradE BI-RADS claSsificaTion Relative tO Other Diagnostic Methodologies (MAESTRO) [NA]
Clinical trial update for MAESTRO study evaluating imaging with opto-acoustics to downgrade BI-RADS classification compared to other diagnos…
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: A Study to Evaluate Changes in Human Breast Cancer Tissue Following Short-Term Use of Darolutamide [EARLY_Phase 1]
Phase 1 study evaluating short-term use of darolutamide and its effects on human breast cancer tissue; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2020-04-02Clinical Trial Update: Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density [Phase 2]
A Phase 2 trial evaluating letrozole for prevention of breast cancer in postmenopausal women at high risk due to dense breast tissue has com…
-
CLINICAL_TRIALS trial_result · 2020-04-02Clinical Trial Update: Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial [Phase 3]
Phase 3 clinical trial evaluating bone mineral density in postmenopausal women with primary breast cancer receiving treatment; completed stu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-04-01Clinical Trial Update: High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer [Phase 3]
Phase 3 trial comparing high-dose chemotherapy with peripheral stem cell transplantation versus standard therapy in metastatic or recurrent …
-
CLINICAL_TRIALS trial_result · 2020-04-01Clinical Trial Update: Tamoxifen in Treating Women With High-Risk Breast Cancer [Phase 3]
Phase 3 clinical trial update on using tamoxifen to treat women at high risk for breast cancer.
-
CLINICAL_TRIALS trial_result · 2020-04-01Clinical Trial Update: Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer [Phase 3]
A Phase 3 trial evaluating tamoxifen with or without octreotide in postmenopausal women with Stage I-III breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-04-01Clinical Trial Update: My Surgical Success: A Randomized Controlled Pilot Study of a Pre-surgical Psychological Intervention [NA]
A randomized controlled pilot study evaluating a pre-surgical psychological intervention for breast cancer patients has completed with resul…
-
CLINICAL_TRIALS trial_result · 2020-03-31Clinical Trial Update: Phase 2 Trial of Pertuzumab and Trastuzumab With Weekly Paclitaxel and Chemotherapy for HER2 Positive Breast Cancer [Phase 2]
Phase 2 trial evaluating pertuzumab and trastuzumab with weekly paclitaxel and chemotherapy for HER2-positive breast cancer has completed wi…
-
CLINICAL_TRIALS trial_result · 2020-03-30Clinical Trial Update: A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer [Phase 3]
This is a Phase 3 clinical trial update for abemaciclib in breast cancer. The study is currently active but not recruiting, and results were…
-
CLINICAL_TRIALS trial_result · 2020-03-30Clinical Trial Update: Vaccine Therapy in Treating Patients With Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating vaccine therapy in breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-03-27Clinical Trial Update: A Study of Pertuzumab With High-Dose Trastuzumab for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (MBC) With Central Nervous System (CNS) Progression Post-Radiotherapy [Phase 2]
Phase 2 trial evaluating pertuzumab with high-dose trastuzumab for HER2-positive metastatic breast cancer with CNS progression after radioth…
-
CLINICAL_TRIALS trial_result · 2020-03-27Clinical Trial Update: Schedules of Nab-Paclitaxel in Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial update evaluating schedules of nab-paclitaxel in metastatic breast cancer completed with results posted.
-
EMA label_change · 2020-03-27No change to product information for breast cancer medicine Tyverb following re-assessment of data
European Medicines Agency states there is no change to the product information for the breast cancer medicine Tyverb after a re-assessment o…
-
CLINICAL_TRIALS trial_result · 2020-03-23Clinical Trial Update: Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination With Hormonal Therapy [Phase 2]
A Phase 2 trial evaluating palbociclib plus fulvestrant in HR+ HER2-negative locally advanced or metastatic breast cancer after prior CDK4/6…
-
CLINICAL_TRIALS trial_result · 2020-03-20Clinical Trial Update: Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors [Phase 1]
Phase I study of lurbinectedin in combination with paclitaxel, with or without bevacizumab, in selected advanced solid tumors (completed; re…
-
FDA label_change · 2020-03-19FDA Approved: ONTRUZANT — Supplemental Application (Organon LLC)
FDA approves a supplemental application for ONTRUZANT (trastuzumab) filed by Organon LLC, resulting in changes to the product labeling.
-
FDA approval · 2020-03-18FDA Approved: LUPRON DEPOT — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for LUPRON DEPOT (leuprolide acetate) submitted by AbbVie Inc.
-
CLINICAL_TRIALS trial_result · 2020-03-17Clinical Trial Update: Assessing the Efficacy of Paclitaxel and Olaparib in Comparison to Paclitaxel / Carboplatin Followed by Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer and Homologous Recombination Deficiency [Phase 2]
Phase 2 trial comparing paclitaxel and olaparib versus paclitaxel/carboplatin followed by epirubicin/cyclophosphamide as neoadjuvant therapy…
-
CLINICAL_TRIALS trial_result · 2020-03-17Clinical Trial Update: Exemestane and Cyclophosphamide for Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating exemestane and cyclophosphamide for metastatic breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-13Clinical Trial Update: NX in Luminal B Breast Cancer Patients After Neoadjuvant Chemotherapy [Phase 3]
Phase 3 clinical trial update for NX in luminal B breast cancer patients after neoadjuvant chemotherapy.
-
CLINICAL_TRIALS trial_result · 2020-03-13Clinical Trial Update: Safety Study Of Chemotherapy Combined With Dendritic Cell Vaccine to Treat Breast Cancer [Phase 1, Phase 2]
A completed Phase 1/2 safety study evaluating chemotherapy combined with a dendritic cell vaccine in breast cancer patients; results posted …
-
CLINICAL_TRIALS research · 2020-03-12Clinical Trial Update: Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women [NA]
A completed clinical trial evaluating collaborative care to reduce depression and increase cancer screening among low-income urban women.
-
CLINICAL_TRIALS trial_result · 2020-03-12Clinical Trial Update: Study to Investigate the Effect of AB-101 in Breast Cancer Survivors [EARLY_Phase 1]
Early-phase study investigating AB-101 in breast cancer survivors; study completed with results posted in 2020.